Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Ourania Tatsis. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Ourania Tatsis har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:VRTX / Vertex Pharmaceuticals Incorporated EVP, Chief Reg. & Quality Off. 46.763
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Ourania Tatsis. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Ourania Tatsis som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2026-02-26 2026-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -260 46.763 -0,55 486,35 -126.451 22.743.185
2026-02-26 2026-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -1.627 47.023 -3,34 485,11 -789.274 22.811.328
2026-02-19 2026-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -368 48.650 -0,75 473,68 -174.314 23.044.532
2026-02-19 2026-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -609 49.018 -1,23 489,46 -298.081 23.992.350
2026-02-19 2026-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.294 49.627 -4,42 483,75 -1.109.722 24.007.061
2026-02-19 2026-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 5.789 51.921 12,55
2026-02-18 2026-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.500 46.132 -3,15 499,99 -749.985 23.065.539
2026-02-18 2026-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3.804 47.632 -7,40 487,76 -1.855.439 23.232.984
2026-02-12 2026-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -466 51.436 -0,90 460,43 -214.560 23.682.677
2026-02-12 2026-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.140 51.902 -3,96 468,41 -1.002.397 24.311.416
2026-01-26 2026-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3.883 54.042 7,74
2026-01-26 2026-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 7.866 50.159 18,60
2026-01-09 2026-01-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.500 42.293 -9,62 474,99 -2.137.455 20.088.752
2025-12-05 2025-12-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.500 46.793 -8,77 449,99 -2.024.955 21.056.382
2025-03-12 2025-03-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.242 51.239 -5,95 499,99 -1.620.968 25.618.988
2025-03-06 2025-03-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.058 54.481 -6,93 485,49 -1.970.118 26.449.981
2025-02-28 2025-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -530 58.539 -0,90 475,34 -251.930 27.825.928
2025-02-28 2025-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -4.962 59.069 -7,75 479,61 -2.379.825 28.330.083
2025-02-26 2025-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -354 64.031 -0,55 480,95 -170.256 30.795.709
2025-02-26 2025-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3.310 64.385 -4,89 483,28 -1.599.657 31.115.983
2025-02-19 2025-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -244 67.695 -0,36 455,06 -111.035 30.805.287
2025-02-19 2025-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.293 67.939 -3,26 463,46 -1.062.714 31.487.009
2025-02-14 2025-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 6.211 70.232 9,70
2025-02-12 2025-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -310 64.021 -0,48 459,83 -142.547 29.438.776
2025-02-12 2025-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.143 64.331 -3,22 467,98 -1.002.881 30.105.621
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 7.114 66.474 11,98
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10.262 59.360 20,90
2024-06-05 2024-06-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.175 49.098 -4,24 460,00 -1.000.500 22.585.080
2024-06-03 2024-05-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.250 51.273 -4,20 445,00 -1.001.250 22.816.485
2024-06-03 2024-05-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.350 53.523 -4,21 439,11 -1.031.908 23.502.485
2024-02-27 2024-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -354 55.804 -0,63 425,70 -150.698 23.755.763
2024-02-27 2024-02-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3.309 56.158 -5,56 431,79 -1.428.793 24.248.463
2024-02-23 2024-02-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -360 59.467 -0,60 421,77 -151.837 25.081.397
2024-02-21 2024-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -480 59.827 -0,80 420,79 -201.979 25.174.603
2024-02-21 2024-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3.373 60.307 -5,30 420,58 -1.418.616 25.363.918
2024-02-21 2024-02-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -4.499 63.680 -6,60 424,01 -1.907.621 27.000.957
2024-02-13 2024-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -314 68.179 -0,46 420,24 -131.955 28.651.543
2024-02-13 2024-02-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.100 68.493 -2,97 422,74 -887.754 28.954.731
2024-02-08 2024-02-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 7.114 70.593 11,21
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 7.866 63.479 14,14
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 6.976 55.613 14,34
2023-08-25 2023-08-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.500 48.637 -4,89 355,00 -887.500 17.266.135
2023-08-14 2023-08-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.750 51.137 -10,11 345,79 -1.988.292 17.682.663
2023-02-28 2023-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -20 56.805 -0,04 289,29 -5.786 16.433.118
2023-02-28 2023-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -51 56.825 -0,09 288,33 -14.705 16.384.352
2023-02-28 2023-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -283 56.876 -0,50 287,20 -81.278 16.334.787
2023-02-28 2023-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3.308 57.159 -5,47 289,12 -956.409 16.525.810
2023-02-22 2023-02-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -124 60.467 -0,20 294,77 -36.551 17.823.858
2023-02-22 2023-02-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -207 60.591 -0,34 293,83 -60.823 17.803.454
2023-02-22 2023-02-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -145 60.798 -0,24 292,85 -42.463 17.804.694
2023-02-22 2023-02-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4 60.943 -0,01 291,01 -1.164 17.735.022
2023-02-22 2023-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -4.498 60.947 -6,87 292,85 -1.317.239 17.848.329
2023-02-16 2023-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -51 65.445 -0,08 300,58 -15.330 19.671.458
2023-02-16 2023-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -135 65.496 -0,21 299,60 -40.446 19.622.602
2023-02-16 2023-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -43 65.631 -0,07 297,98 -12.813 19.556.725
2023-02-16 2023-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -20 65.674 -0,03 296,48 -5.930 19.471.028
2023-02-16 2023-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -71 65.694 -0,11 295,89 -21.008 19.438.198
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11 65.765 -0,02 300,79 -3.309 19.781.454
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -64 65.776 -0,10 299,88 -19.192 19.724.907
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -120 65.840 -0,18 298,98 -35.878 19.684.843
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -78 65.960 -0,12 298,11 -23.253 19.663.336
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2 66.038 0,00 295,84 -592 19.536.682
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.995 66.040 -4,34 298,26 -893.289 19.697.090
2023-02-14 2023-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -1.377 69.035 -1,96 294,33 -405.292 20.319.072
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 7.866 70.412 12,58
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10.262 62.546 19,63
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 6.194 52.284 13,44
2022-08-10 2022-08-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -74 46.090 -0,16 301,67 -22.324 13.903.970
2022-08-10 2022-08-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -72 46.164 -0,16 300,64 -21.646 13.878.745
2022-08-10 2022-08-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -283 46.236 -0,61 299,79 -84.841 13.861.090
2022-08-10 2022-08-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -679 46.519 -1,44 298,77 -202.865 13.898.482
2022-08-10 2022-08-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -292 47.198 -0,61 297,54 -86.882 14.043.293
2022-03-21 2022-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -34 47.356 -0,07 251,24 -8.542 11.897.721
2022-03-21 2022-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.799 47.390 -5,58 250,10 -700.030 11.852.239
2022-02-28 2022-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -18 50.189 -0,04 232,80 -4.190 11.683.999
2022-02-28 2022-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -87 50.207 -0,17 231,81 -20.167 11.638.485
2022-02-28 2022-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -115 50.294 -0,23 230,97 -26.562 11.616.405
2022-02-28 2022-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -77 50.409 -0,15 230,26 -17.730 11.607.176
2022-02-28 2022-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -28 50.486 -0,06 228,88 -6.409 11.555.236
2022-02-28 2022-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.590 50.514 -4,88 227,86 -590.157 11.510.120
2022-02-22 2022-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -120 53.104 -0,23 233,48 -28.018 12.398.722
2022-02-22 2022-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -80 53.224 -0,15 232,04 -18.563 12.350.097
2022-02-22 2022-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -101 53.304 -0,19 230,42 -23.272 12.282.308
2022-02-22 2022-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -218 53.405 -0,41 229,52 -50.035 12.257.516
2022-02-22 2022-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -4.114 53.623 -7,13 232,51 -956.546 12.467.884
2022-02-14 2022-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -42 57.737 -0,07 236,85 -9.948 13.675.008
2022-02-14 2022-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -70 57.779 -0,12 235,87 -16.511 13.628.333
2022-02-14 2022-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -78 57.849 -0,13 234,93 -18.325 13.590.466
2022-02-14 2022-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 57.927 -0,17 233,92 -23.392 13.550.284
2022-02-14 2022-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -1.230 58.027 -2,08 237,74 -292.420 13.795.339
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10.262 59.257 20,94
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 13.952 48.995 39,81
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3.500 35.043 11,10
2021-02-26 2021-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -1.036 31.432 -3,19 217,57 -225.403 6.838.660
2021-02-19 2021-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.000 32.468 -5,80 211,75 -423.500 6.875.099
2021-02-12 2021-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -1.230 34.468 -3,45 214,16 -263.417 7.381.667
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 13.952 35.698 64,16
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 6.194 21.746 39,83
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2.814 15.552 22,09
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9 12.738 -0,07 288,38 -2.595 3.673.384
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -33 12.747 -0,26 287,61 -9.491 3.666.165
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -20 12.780 -0,16 286,12 -5.722 3.656.614
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10 12.800 -0,08 284,30 -2.843 3.639.040
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -21 12.810 -0,16 281,23 -5.906 3.602.556
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -17 12.831 -0,13 279,93 -4.759 3.591.782
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10 12.848 -0,08 276,35 -2.764 3.550.545
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -407 2.854 -12,48
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -559 6.145 -8,34
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -30 12.738 -0,23 275,30 -8.259 3.506.771
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -330 12.768 -2,52 274,13 -90.463 3.500.092
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -210 13.098 -1,58 273,15 -57.362 3.577.719
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -217 13.308 -1,60 272,09 -59.044 3.620.974
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -136 13.525 -1,00 270,19 -36.746 3.654.320
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -43 13.661 -0,31 268,80 -11.558 3.672.077
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 407 13.704 3,06 155,57 63.317 2.131.931
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 559 13.297 4,39 187,53 104.829 2.493.586
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -240 12.738 -1,85 237,81 -57.074 3.029.224
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -160 12.978 -1,22 235,39 -37.662 3.054.891
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -240 13.138 -1,79 234,43 -56.263 3.079.941
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -80 13.378 -0,59 232,43 -18.594 3.109.449
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -160 13.458 -1,17 231,82 -37.091 3.119.834
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -416 13.618 -2,96 229,57 -95.501 3.126.284
2020-02-26 2020-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -1.036 14.034 -6,87 239,23 -247.842 3.357.354
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -145 15.070 -0,95 245,75 -35.634 3.703.452
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -286 15.215 -1,85 244,99 -70.067 3.727.523
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -160 15.501 -1,02 243,78 -39.005 3.778.834
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -528 15.661 -3,26 242,78 -128.188 3.802.178
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -160 16.189 -0,98 241,82 -38.691 3.914.824
2020-02-19 2020-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -597 16.349 -3,52 241,50 -144.176 3.948.284
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -408 3.261 -11,12
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -559 6.704 -7,70
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -66 16.946 -0,39 242,47 -16.003 4.108.897
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -90 17.012 -0,53 240,70 -21.663 4.094.788
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -240 17.102 -1,38 239,68 -57.523 4.099.007
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -571 17.342 -3,19 238,77 -136.338 4.140.749
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 408 17.913 2,33 155,57 63.473 2.786.725
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 559 17.505 3,30 187,53 104.829 3.282.713
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 6.194 16.946 57,61
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3.500 10.752 48,26
2020-01-10 2020-01-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.675 7.263 -18,74
2020-01-10 2020-01-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.675 7.252 -18,76 227,53 -381.113 1.650.048
2020-01-10 2020-01-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.675 8.927 23,10 187,53 314.113 1.674.080
2019-11-19 2019-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5 7.252 -0,07 205,95 -1.030 1.493.549
2019-11-15 2019-11-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -2.853 3.669 -43,74
2019-11-15 2019-11-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.853 7.252 -28,23 205,59 -586.548 1.490.939
2019-11-15 2019-11-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.853 10.105 39,34 155,57 443.841 1.572.035
2019-10-03 2019-10-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -444 7.252 -5,77 167,69 -74.454 1.216.088
2019-10-03 2019-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -188 7.696 -2,38 169,11 -31.793 1.301.471
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
11.384
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
9.760
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.516
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
9.760
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
11.384
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
9.760
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.516
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
9.760
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
11.384
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
9.760
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.516
2019-10-03 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
9.760
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)